Location History:
- Funabashi, JP (2015)
- Chuo-ku, JP (2022)
Company Filing History:
Years Active: 2015-2022
Title: Toshihiro Kiho: Innovator in Stem Cell and Bone Metabolism Research
Introduction
Toshihiro Kiho is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the fields of stem cell research and bone metabolism through his innovative patents. With a total of 2 patents, Kiho continues to push the boundaries of scientific discovery.
Latest Patents
One of Kiho's latest patents is a dihydroindolizinone derivative. This compound is designed to efficiently induce differentiation from pluripotent stem cells into insulin-producing cells. The invention aims to provide a new compound that can significantly impact diabetes treatment. Another notable patent is a chromone derivative that promotes osteogenesis. This compound is intended for improving bone metabolism, preventing or treating bone fractures, and addressing diseases associated with bone metabolism. It has applications in orthopedics and dentistry, particularly for the treatment of periodontal disease and the stabilization of artificial tooth roots.
Career Highlights
Toshihiro Kiho is currently associated with Daiichi Sankyo Company, Limited, where he applies his expertise in pharmaceutical research and development. His work focuses on creating innovative solutions that address critical health issues.
Collaborations
Kiho collaborates with esteemed colleagues, including Tatsuya Yano and Satoshi Komoriya. These partnerships enhance the research and development process, leading to groundbreaking advancements in their respective fields.
Conclusion
Toshihiro Kiho's contributions to stem cell and bone metabolism research exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes and advancing scientific knowledge.